In order to enable an iCal export link, your account needs to have an API key created. This key enables other applications to access data from within Indico even when you are neither using nor logged into the Indico system yourself with the link provided. Once created, you can manage your key at any time by going to 'My Profile' and looking under the tab entitled 'HTTP API'. Further information about HTTP API keys can be found in the Indico documentation.
Additionally to having an API key associated with your account, exporting private event information requires the usage of a persistent signature. This enables API URLs which do not expire after a few minutes so while the setting is active, anyone in possession of the link provided can access the information. Due to this, it is extremely important that you keep these links private and for your use only. If you think someone else may have acquired access to a link using this key in the future, you must immediately create a new key pair on the 'My Profile' page under the 'HTTP API' and update the iCalendar links afterwards.
Permanent link for public information only:
Permanent link for all public and protected information:
WSMD2017 - Workshop on Schizophrenia and other Mental Disorders
Largo Bruno Pontecorvo, 3
Alberto Del Guerra
The aims of the Workshop on Schizophrenia and other mental disorders are to showcase the latest developments in EU-funded research in the field of brain imaging tools for mental disorders (diagnosis, monitoring and management) and to explore the research and innovation challenges to be addressed for advancing the field.
The Workshop will bring together the investigators involved in collaborative research projects funded by the EU through the Seventh Framework Programme (call HEALTH.2013.2.2.1-2: Development of effective imaging tools for diagnosis, monitoring and management of mental disorders) and the "Innovative Medicines Initiative". EU-funded projects on neurodegenerative diseases will also be represented to gain a broader view on the state-of-play of brain imaging tools for brain disorders.
Participants will present their results and have the possibility to interact and discuss their findings. It will also be an opportunity to explore how to coordinate their efforts and capitalise on their results.
The Workshop will conclude with a roundtable with selected panellists who will discuss how to best address challenges and needs identified by the participants during the event.
The Workshop is organised in collaboration with the European Commission Directorate General for Research and Innovation and the EU Joint Undertaking Initiative "Innovative Medicines Initiative" and is under the patronage of the European Psychiatric Association.
PSYSCAN: Translating neuroimaging findings from research into clinical practice30m
(King's College London)
TRIMAGE: A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia30m
Alberto Del Guerra
MINDVIEW: Multimodal Imaging of Neurological Disorders30m
(University of Valencia)
The view of the Pharmaceutical European Industry in Neuroscience30m
(Johnson & Johnson)
Status of the FP7 and Horizon 2020 funded projects on mental disorders (continued)
(Gregorio Marañón Hospital), Paolo Brambilla
(University of Milano)
IMAGEMEND: IMAging GEnetics for MENtal Disorders30m
(University of Bari)
BRAINTRAIN: Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders30m
(Cardiff University (UK))
BIOCOG: Biomarker Development for Postoperative Cognitive Impairment in the Elderly30m
Georg Winterer Charité
(Universitätsmedizin Berlin (Germany))
METSY: Neuroimaging platform for characterisation of metabolic co-morbidities in psychotic disorders30m
(University of Turku (Finland))
LIFEBRAIN: Healthy minds from 0-100 years: Optimising the use of European brain imaging cohorts30m
Klaus P. Ebmeier
(University of Oxford (UK))
The IMI contribution in Brain studies
(University of Milano (Italy)), Karsten Heekeren
(University of Zürich (Switzerland))
The IMI consortium and the IMI funded projects in Central Nervous System (CNS)30m
RADAR CNS: Use of Wearable Devices and Mobile Technology to Understand the Course of Brain Diseases30m
(Janssen Pharmaceuticals (Belgium))
PRISM: Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in Alzheimer’s Disease, Schizophrenia, and Mayor Depression30m